FOR HEALTHCAREPROFESSIONALS
Watch the TV spot that may have patients asking about XIFAXAN.
Unlike other prescription IBS-D treatments, XIFAXAN is:
ALT = alanine aminotransferase
NA = not available
*Most of the events of ALT increased were due to transient increases that resolved over time and were not temporally associated with study drug treatment.2
Find access and savings information
IBS-D = irritable bowel syndrome with diarrhea
†The ICD-10 Codes and all other patient access related information are provided for informational purposes only. It is the treating physician’s responsibility to determine the proper diagnosis, treatment and applicable ICD-10 Code. Salix Pharmaceuticals does not guarantee coverage or reimbursement for the product.
In the know: Ask patients to track IBS-D symptoms
See how XIFAXAN is believed to work
Look up insurance coverage
Thank you for visiting the XIFAXAN Professional website. By clicking OK, you will be taken to a website or sites where our Privacy Policy and other rules do not apply. Salix Pharmaceuticals does not possess editorial control over the content of the information on such website(s) and therefore does not warrant their accuracy and completeness. You are solely responsible for interactions with such website(s).
The information contained in this section of the site is intended for US healthcare professionals only.
Get information regarding XIFAXAN
Speak with a XIFAXAN representative
XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.